This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Janssen Pharmaceutica Nv. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ivo Cornelissen: Innovator in Cancer Treatment
Introduction
Ivo Cornelissen is a notable inventor based in Turnhout, Belgium. He has made significant contributions to the field of oncology through his innovative research and development efforts. His work primarily focuses on the treatment of malignancies, showcasing his commitment to advancing medical science.
Latest Patents
Ivo Cornelissen holds a patent for "Inhibitors of Bruton's tyrosine kinase and methods of their use." This patent is directed towards the use of a compound of Formula (III) in the treatment of various malignancies. His innovative approach aims to provide new therapeutic options for patients suffering from cancer.
Career Highlights
Ivo Cornelissen is associated with Janssen Pharmaceutica NV, a leading pharmaceutical company known for its dedication to healthcare innovation. His role at the company has allowed him to collaborate with other experts in the field, further enhancing his contributions to cancer research.
Collaborations
Some of his notable coworkers include Kathryn Elizabeth Packman and Navin Rao. Their collaborative efforts have played a crucial role in advancing the research and development of new cancer treatments.
Conclusion
Ivo Cornelissen's work exemplifies the spirit of innovation in the medical field, particularly in the fight against cancer. His patent and collaborations highlight the importance of teamwork in achieving breakthroughs that can significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile